|
1. Nicolini G, Canta A, Oggioni N,
Rigolio R, Cossa G, Lombardi R, Roglio I, Cervellini I, Lauria G,
Melcangi RC, Bianchi R, Crippa D, Cavaletti G. Experimental epothilone B
neurotoxicity: results of in vitro and in vivo studies. Neurobiol Dis, May 21 [Epub ahead of print]
2.
Lauria G,
Campanella A, Filippini G, Martini A, Penza P, Maggi L, Antozzi C, Ciano C, Beretta P, Caldiroli D, Ghelma
F, Ferrara G, Ghezzi P,
Mantegazza R. Erythropoietin in Amyotrophic Lateral Sclerosis: A pilot,
randomised, double-blind, placebo-controlled study of safety and tolerability. Amyotrophic Lat Sclerosis, May 29 [Epub ahead of print]
3. Canta A, Chiorazzi A, Meregalli
C, Carozzi V, Oggioni N, Lauria G, Bianchi R, Nicora MF, Cavaletti G.
Continuous buprenorphine delivery effect in streptozotocine-induced painful
diabetic neuropathy in rats. J Pain in
press
4. Rigamonti A, Lauria G,
Balgera R, Agostoni E. Subacute inflammatory polyradiculopathy associated with
Sjögren’s syndrome. Muscle Nerve. 2009,39(6):855-7
5. Roglio I, Bianchi R, Camozzi F,
Carozzi V, Cervellini I, Crippa D, Lauria G, Cavaletti G, Melcangi RC. Docetaxel-induced peripheral neuropathy: protective effects of
dihydroprogesterone and progesterone in an experimental model. J Peripher Nerv Syst. 2009 Mar;14(1):36-44.
6.
Penza P, Lombardi R,
Camozzi F, Ciano C, Lauria G. Painful neuropathy in subclinical
hypothyroidism: clinical and neuropathological recovery after hormone
replacement therapy. Neurol Sci. 2009
Apr;30(2):149-51.
7.
RMC Trial Group. Randomised controlled trial of
methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC
trial): a pilot, multicentre study. Lancet
Neurol. 2009 Feb;8(2):158-64.
8.
England JD, Gronseth GS, Franklin G, Carter GT,
Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low
PA, Fisher MA, Herrmann D, Howard JF, Lauria G, Miller RG, Polydefkis M,
Sumner AJ; American Academy of Neurology; American Association of Neuromuscular
and Electrodiagnostic Medicine; American Academy of Physical Medicine and
Rehabilitation. Evaluation of distal symmetric polyneuropathy: The role of
laboratory and genetic testing (an evidence-based review). Muscle Nerve. 2009;39(1):116-25
9. England JD,
Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti
K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, Lauria
G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology;
American Association of Neuromuscular and Electrodiagnostic Medicine; American
Academy of Physical Medicine and Rehabilitation. Evaluation of distal symmetric
polyneuropathy: The role of autonomic testing, nerve biopsy, and skin biopsy
(an evidence-based review). Muscle Nerve. 2009;39(1):106-15.
10.
Lauria G,
Lombardi R, Camozzi F, Devigili G. Skin biopsy for the diagnosis of
peripheral neuropathy. Histopathology. 2009 Feb;54(3):273-85.
11.
J.D. England, G.S. Gronseth, G. Franklin, G.T. Carter,
L.J. Kinsella, J.A. Cohen, A.K. Asbury, K. Szigeti, J.R. Lupski, N. Latov, R.A.
Lewis, P.A. Low, M.A. Fisher, D. Herrmann, J.F. Howard, G. Lauria, M.
Polydefkis, A.J. Summer. Practice
Parameter: The evaluation of distal symmetric polyneuropathy: the role of
laboratory and genetic testing (an evidence-based review). Report of the
American Academy of Neurology, the American Association of Neuromuscular and
Electrodiagnostic Medicine, and the American Academy of Physical Medicine and
Rehabilitation. Neurology. 2009 Jan
13;72(2):185-92.
12. J.D. England, G.S.
Gronseth, G. Franklin, G.T. Carter, L.J. Kinsella, J.A. Cohen, A.K. Asbury, K.
Szigeti, J.R. Lupski, N. Latov, R.A. Lewis, P.A. Low, M.A. Fisher, D. Herrmann,
J.F. Howard, G. Lauria, M. Polydefkis, A.J. Summer. Practice Parameter: The evaluation of
distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy,
and skin biopsy (an evidence-based review) Report of the American
Academy of Neurology, the American
Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and
Rehabilitation. Neurology. 2009 Jan
13;72(2):177-84
13.
Penza P, Campanella A,
Martini A, Melli G, Lombardi R, Camozzi F,
Devigili G, Lauria G. Short and intermediate-term efficacy of
buprenorphine TDS in chronic painful neuropathies. J Periph Nerv System,
2008;13(4):283-8.
14. Melli G, Taiana M, Camozzi F, Triolo D,
Podini P, Quattrini A, Taroni F, Lauria G. Alpha-lipoic acid prevents
mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
Exp Neurol.
2008;214(2):276-84
15.
Devigili G, Tugnoli V, Penza
P, Camozzi F, Lombardi R, Melli G, Broglio L, Granieri E, Lauria
G. The diagnostic criteria for small fibre neuropathy: from symptoms
to neuropathology. Brain 2008;131(Pt 7):1912-25
16. van Nes SI, Faber CG, Hamers RM,
Harschnitz O, Bakkers M, Hermans MC, Meijer RJ, van Doorn PA, Merkies IS;
Bennett D, van den Berg LH, Van den Bergh PY, Cornblath DR, DalakaS M, van
Doorn PA, Faber CG, Gorson KC, Hadden RD, Hahn AF, Hughes RA, Lauria G,
Léger JM, Lewis RA, Lunn PT, Merkies IS, Nobile-Orazio E, Noterman S NC, Padua
L, Reilly MM. Revising
two-point discrimination assessment in normal aging and in patients with
polyneuropathies. J Neurol Neurosurg
Psychiatry. 2008 Jul;79(7):832-4.
17. Magnaghi, V,
Ballabio M, Camozzi F, Colleoni M, Consoli A, Gassmann M, Lauria G,
Motta M, Procacci P, Trovato AE, Bettler B. Altered peripheral myelination and pain perception in
mice lacking GABA-b receptors. Mol Cell Neurosci 2008;37:599–609
18.
Focosi
D, Kast RE, Maggi F, Lauria G, Ceccherini-Nelli L, Petrini M. 5-HT2a
inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old
disease. J Infect Dis 2008;197(2):328
19. Solari A,
Laura` M, Salsano E, Radice D, Pareyson D, On behalf of the CMT-TRIAAL Study Group. Reliability of
clinical outcome measures in Charcot-Marie-Tooth disease. Neuromuscul Disord. 2008;18(1):19-26.
20.
Roglio I, Giatti S,
Pesaresi M, Bianchi R, Cavaletti G, Lauria G, Garcia-Segura LM,
Melcangi RC. Neuroactive steroids and peripheral neuropathy. Brain Res Reviews 2008;57(2):460-9.
21. Lauria G, Lombardi R. Skin biopsy: a new tool for
diagnosing peripheral neuropathy. Br Med
J 2007;334(7604):1159-1162
22. Lauria G, Devigili G. Skin biopsy as a diagnostic tool
in peripheral neuropathies. Nature Clinical Practice Neurology 2007, Oct;3(10):546-57.
23.
Sommer C, Lauria G.
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's
disease? Lancet Neurology 2007;6:849
24.
Sommer C, Lauria G.
The use of skin biopsy in the management of peripheral neuropathy. Lancet Neurology 2007; 6:632-642.
25.
Lauria
G. Recent developments in
the management of peripheral neuropathy using skin biopsy. Rev Neurologique
2007;163:1266-1270
26. Marucci G, Morandi L, Bartolomei I, Salvi F, Pession A,
Righi A, Lauria
G, Foschini MP. Amyotrophic lateral
sclerosis with mutation of the Cu/Zn superoxide dismutase gene (SOD1) in a
patient with Down syndrome. Neuromuscul
Disord. 2007;17(9-10):673-6.
27.
Rigamonti A, Magi
S, Venturini E, Morandi L, Ciano C, Lauria G. Celiac disease
presenting with motor neuropathy: effect of gluten free-diet. Muscle Nerve 2007;35(5):675-677
28.
Roglio I, Bianchi R,
Giatti S, Cavaletti G, Caruso D, Scurati S, Crippa D, Garcia-Segura LM, Camozzi
F, Lauria G, Melcangi RC. Testosterone
derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol Life Sci 2007;64(9):1158-68.
29.
Bianchi R, Giardini A,
Rodriguez-Menendez V, Oggioni N, Canta A, Colombo T, De Michele G, Martone S,
Sfacteria A, Piedemonte G, Grasso G, Beccaglia P, Ghezzi P, D'Incalci M, Lauria
G, Cavaletti G. Cisplatin-induced peripheral neuropathy: neuroprotection by
erythropoietin without affecting tumour growth. Eur J Cancer 2007;43:710-717.
30.
Leonelli
E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria
G, Magnaghi V, Roglio I, Melcangi RC. Progesterone and its
derivatives are neuroprotective agents in experimental diabetic neuropathy:
biochemical and functional analyses. Neuroscience
2007;144:1293-1304.
31. Restivo DA,
Marchese-Ragona R, Lauria G, Squatrito S, Gullo D, Vigneri R. Botulinum
toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy.
Diabetes Care
2006;29:2650-2653.
32.
Lauria G,
Morbin M, Lombardi R, Capobianco R, Camozzi F, Pareyson D, Manconi M, Geppetti
P. Expression of capsaicin receptor
immunoreactivity in human peripheral nervous system and in painful
neuropathies. J
Periph Nerv Syst 2006,11:262–271
33. Bianchi R, Brines
M, Lauria G, Savino C, Giardini A, Nicolini G, Rodriguez-Menendez V,
Oggioni N, Canta A, Penza P,
Lombardi R, Minoia C, Ronchi A, Cerami A, Ghezzi P, Cavaletti G. Protective effect of erythropoietin and of its carbamylated derivative in
experimental cisplatin peripheral neurotoxicity. Clin Cancer Res 2006;12:2607-2612.
34. Merkies IS, Lauria G. 131st ENMC
international workshop: selection of outcome measures for peripheral neuropathy
clinical trials 10-12 December 2004, Naarden, The Netherlands. Neuromuscul
Disord. 2006;16:149-156.
35.
Sghirlanzoni A, Pareyson D,
Lauria G. Sensory neuron diseases. Lancet Neurology 2005;4:349-361
36.
Lombardi R, Erne B, Lauria G, Pareyson D,
Borgna M, Morbin M, Arnold A, Czaplinski A, Fuhr P, Schaeren-Wiemers N, Steck
AJ. IgM deposits on skin
nerves in anti–myelin-associated glycoprotein neuropathy. Ann Neurol 2005;
57:180 –187
37.
Lauria
G, Majorana A,
Borgna M, Lombardi R, Penza P,
Padovani A, Sapelli P. Trigeminal small-fiber sensory neuropathy causes burning
mouth syndrome. Pain 2005;115:332–337.
38.
Lauria
G. Skin biopsy in the
diagnosis of peripheral neuropathies. Practical Neurology 2005;5:92-99.
39.
Lauria G, Cornblath DR, Johansson O, McArthur, S.I.
Mellgren, M. Nolano, N. Rosenberg, C. Sommer. EFNS Guidelines on the use of skin biopsy in the diagnosis of peripheral
neuropathy. Eur J Neurol 2005;12: 747–758
40.
Lauria G, Lombardi R, Borgna M, Penza P, Bianchi
R, Savino C, Canta A, Nicolini G, Marmiroli P,
Cavaletti G. Intraepidermal nerve fiber density in rat footpad:
neuropathologic - neurophysiologic correlation. J Periph Nerv Syst
2005;10:199–205.
41.
Lauria G. Small fibre neuropathy. Curr
Opin Neurol 2005;18:591–597
42. Broglio L, Lauria
G. Worsening after rituximab treatment in anti-MAG neuropathy. Muscle Nerve
2005; 32:378-9
43. Lauria
G. Semeiologia e clinica delle neuropatie sensitive. Neurol Sci
2005;26:S301-S304.
44.
Lauria
G, Borgna M, Morbin M,
Lombardi R, Mazzoleni G, Sghirlanzoni A, Pareyson D. Tubule and neurofilament
immunoreactivity in human hairy skin: markers for intraepidermal nerve fibers. Muscle
Nerve 2004;30:310-316.
45.
Bianchi
R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G,
Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kanik A, Tataroglu C, Cerami A,
Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic
neuropathy. Proc Natl Acad Sci U S A 2004;10:823-828
46. Lauria G, Lombardi R, Borgna M. L'innervazione della cute nell'uomo: da Paul
Langerhans alle attuali procedure diagnostiche. Neurol
Sci 2004; 25:S419-S422.
47. Lauria G, Morbin M, Lombardi R, Borgna M, Mazzoleni G,
Sghirlanzoni A, Pareyson D. Axonal swellings predict the degeneration of
epidermal nerve fibers in painful neuropathies. Neurology 2003;61:631-636
48. Lauria G, Pareyson D,
Pitzolu MG, Bazzigaluppi E. Excellent
response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurology 2003;2:634-635
49. Lauria G, Pareyson D, Sghirlanzoni A. Neurophysiological
diagnosis of acquired sensory ganglionopathy. Eur Neurol 2003;50:146-152
50. Pareyson D, Testa D, Morbin M, Erbetta A,
Ciano C, Lauria G, Milani M, Taroni F. Does CMT1A homozygosity cause
more severe disease with root hypertrophy and higher CSF proteins? Neurology 2003;60:1721-1722.
51. Pareyson D, Sghirlanzoni A, Lauria
G. Algoritmo diagnostico: dal sintomo alla causa. Polineuropatie sensitive.
Neurol Sci 2003;24:S677-S680.
52. Pareyson
D, Scaioli V, Ciano C, Lauria G, Sghirlanzoni A, Taroni F. Neuropatie di
Charcot-Marie-Tooth: rivisitazione della neurofisiopatologia nell’era della
genetica molecolare. Neurol Sci
2002;23:S461-S466
53. Lauria G, Pareyson D,
Sghirlanzoni A. Sensory
ganglionopathies: causes and neuroradiological findings. N Engl J Med 2002;346:1029-1030.
54. Lauria G, Sghirlanzoni A, Lombardi R, Pareyson D. Epidermal
innervation in sensory ganglionopathies – Clinical and neurophysiological
correlations. Muscle Nerve
2001;24:1034-1039.
55. Lauria G, Erbetta A, Pareyson D,
Sghirlanzoni A. Parenchymatous neurosyphilis. Neurol Sci 2001;22:281-282.
56. Pareyson D, Lauria G,
Sghirlanzoni A. La terapia con immunoglubuline (IVIg) nelle neuropatie
disimmuni. Neurol Sci 2001;22:S431-S435.
57. Lauria G, Chiapparini L, Pareyson D,
Sghirlanzoni A. Spinal cord lesion due to epidural anesthesia. Neurol Sci 2000;21:411-412.
58. Lauria G, Pareyson D, Grisoli M, Sghirlanzoni A. Clinical and
MRI findings in chronic sensory ganglionopathies. Ann Neurol 2000;47:104-109.
59. Lauria G, Pareyson D, Sghirlanzoni A. Chronic cryptogenic
sensory polyneuropathy. Arch Neurol 2000:57:759-760.
60. Pareyson D, Taroni F, Botti S, Morbin M,
Baratta S, Lauria G, Ciano C, Sghirlanzoni A. Cranial nerve involvement
in CMT disease type 1 due to early growth response gene mutation. Neurology 2000;54:1696-1698.
61. Sghirlanzoni A, Lauria G,
Lombardi R, Pareyson D. Diagnostica differenziale delle ganglionopatie
paraneoplastiche. Neurol Sci
2000;21:S273-S275.
62. Lauria G, Holland
N, Hauer PE, Cornblath DR,
Griffin JW, McArthur JC.
Epidermal innervation: changes with aging, topographic location, and sensory
neuropathy. J Neurol Sci 1999;164:172-178.
63. Lauria G. Innervation of the human epidermis. A historical
review. Ital J Neurol Sci 1999;20:63-70.
64. Casetta I, Granieri E, Gilli G, Lauria G,
Tola MR, Paolino E. Temporal trend and factors associated with delayed hospital
admission of stroke patients. Neuroepidemiology
1999;18:255-264
65. Lauria G, McArthur JC, Hauer PE, Griffin JW, Cornblath DR.
Neuropathological alterations in diabetic truncal neuropathy: evaluation by
skin biopsy. J Neurol Neurosurg
Psychiatry 1998;65:762-766.
66. Flanigan KM, Lauria G, Griffin JW, Kuncl RW. Age
related biology and diseases of muscle and nerves. Neurologic Clinics 1998:659-669.
67. Lauria G, Gentile M, Fassetta G, et al. Transient global amnesia and transient
ischemic attack: a community-based case-control study. Acta Neurol Scand 1998;97:381-385.
68. Casetta I, Granieri E, Marchi D,
Murgia SB, Tola MR, Ticca A, Lauria G, Govoni V, Murgia B, Pugliatti M.
An epidemiologic study of multiple sclerosis in central Sardinia, Italy. Acta Neurol Scand 1998;98:391-394.
69. Lauria G, Gentile M, Fassetta G, et al. Incidence of transient global amnesia in
the Belluno province, Italy: 1985 through 1995. Results of a community-based
study. Acta Neurol Scand 1997;95:303-310.
70.
Barrella
M, Lauria G, Quatrale R, Paolino E. Hypokaliemic rhabdomyolisis
associated with liquorice ingestion: report of an atipical case. Ital J Neurol Sci 1997;18:217-220.
71.
Lauria G,
Gentile M, Fassetta G, et al. Incidence
of transient ischemic attacks in the Belluno province, Italy. First-year
results of a community-based study. Acta
Neurol Scand 1996;93:291-296.
72. Granieri E, Tamburin S, Lauria
G, et al. Attualità sulla malattia di Creutzfeldt-Jakob e sindromi
correlate. Sorveglianza epidemiologica nell’Italia settentrionale e in
Sardegna. L’Arcispedale S. Anna
1996;46:151-199.
73. Lauria G, Gentile M, Fassetta G, et al. Incidence and prognosis of stroke in the
Belluno province, Italy. First-year results of a community-based study. Stroke 1995;26:1787-1793.
74. Zanchin G, De Boni A, Lauria G,
Maggioni F, Rossi P,
Villacara A. Synaptosomal glutamate uptake in a model of experimental cerebral
ischemia. Neurochem Research
1995;20:195-199.
75. Gentile M, Lauria G. Cephalic
tetanus presenting with incomplete Bell’s palsy. Ital J Neurol Sci 1994;15:111-113
76. Villacara A, Lauria G,
Maggioni F, et al. Alterazioni neurotrasmettitoriali in corso di ischemia
cerebrale sperimentale. In: Neurorianimazione e Neuroprotezione in
Rianimazione e Terapia Intensiva - Attualitá e prospettive. San Marco, ed., Padova, 1994;27-32.
77.
Gentile M, Lauria G, Perelli P, Martinelli F. La diaschisi
cerebellare crociata: diagnosi differenziale fra TIA e stroke mediante HM-PAO
SPECT. Neurologia Ospedaliera Italiana 1994;3:69-74.
78. Villacara A, Garbin L, Lauria G,
Zanchin G, Galzigna L. Substrate-stimulated oxygen consumption by isolated rat
brain microvessels in the presence and absence of ATP. Neurochem Research 1993;18:1113-1116.
Book chapters
1.
Sommer C., Lauria G.
Painful small fiber sensory neuropathies. In: Handbook
of Clinical Neurology, PJ Vinken & GW Bruyn
(eds), 2005
2.
Lauria G. La gestione della cervicobrachialgia.
In: Neuropatie periferiche: casi clinici. SEEd
srl, Torino, Giugno 2007
3. Lauria G, Nolano M. La biopsia
cutanea nella pratica clinica. In: Trattato di Neuropatologia. G.L. Mancardi, F.
Tagliavini, G. Vita (eds), Elsevier: Amstredam, New York, 2005
4. Sghirlanzoni A, Lauria G,
Pareyson D. Malattie del sistema nervoso periferico. In: Terapia delle
malattie neurologiche con principi di diagnosi. A. Sghirlanzoni, G. Lauria,
D. Pareyson, N. Nardocci (eds). Edi-Ermes: Milano, 2004
5. Lauria G. Spasticità. In: Terapia
delle malattie neurologiche con principi di diagnosi. A. Sghirlanzoni, G.
Lauria, D. Pareyson, N. Nardocci (eds). Edi-Ermes: Milano, 2004
6. Sghirlanzoni
A, Lauria G. Complicazioni della Chemioterapia. In Le Complicazioni Neurologiche in Oncologia Caraceni A, Sghirlanzoni A, Simonetti F (Eds). Springer, Milano, 2006
7. Sghirlanzoni
A, Lauria G. Complicazioni della Radioterapia. In Le Complicazioni Neurologiche in Oncologia Caraceni A, Sghirlanzoni A, Simonetti F (Eds). Springer, Milano, 2006
8. Sghirlanzoni
A, Lauria G. Principali Complicazioni Neurologiche della Chirurgia Oncologica.
In Le Complicazioni Neurologiche in
Oncologia Caraceni A, Sghirlanzoni
A, Simonetti F (Eds). Springer, Milano, 2006
Books
1. Terapia delle malattie
neurologiche con principi di diagnosi. A. Sghirlanzoni, G. Lauria, D. Pareyson,
N. Nardocci (eds). Edi-Ermes: Milano, 2004
2. Sghirlanzoni, G. Lauria, D.
Pareyson (eds). Localizzazione delle lesioni nel Sistema Nervoso Periferico.
I&V Publisher, Milano, 2001.
|